buoyantintelligence
  • 01Overview
  • 02Portfolio
  • 03Company Atlas
    • Buoyant book
    • All listed companies
  • 04Screener & valuation
  • 05House view
  • 06Markets
  • 07India top-down
  • 08Investors
  • 09Library & data
Release
August 2026 · rev 1
Opportunities PMS · Published
As at 31 Aug 2026 · IST₹ · ₹ cr · BSE 500 TRI
Present
Internal working platform. Published figures are extracted from the August 2026 source package and reviewed; reference prices and fundamentals are unlicensed working data, not for redistribution. Past performance is not indicative of future returns.
Company Atlas/Insurance/ICICI Lombard General Insurance
NSE: ICICIGI· InsuranceCyclical · Aug 26Mid cap

ICICI Lombard General Insurance

Motor-TP recovery at a two-year low

Last close
₹1,515.00
29 Sept 2026 · reference
1D · 1M
−1.6% · −3.0%
price-only
Weight
3.1%
31 Jul 2026 · Aug rank 8
Thesis review
8 Sep 2026
Why We Own, p36
Coverage owner: Research (per book); latest results Q Jun-26Buoyant AIF I Top 30 Holdings - Aug 2026.pdf · p1Buoyant_Why_We_Own_What_We_Own_Sep2026.pdf (portfolio as of 31 July 2026) · p36Screener ↗Tijori ↗NSE ↗
OverviewBusiness & segmentsChartsFinancialsValuationThesisRisks & catalystsCompetitorsResearch & documents
Broker research · 1 report

Sell-side views, extracted from the PDFs on file

Motilal OswalNeutralresult update
Significant miss in PAT and CoR
15 Jul 2026 · Prayesh Jain, Nitin Aggarwal, Kartikeya Mohata · 12 pp · open PDF ↗
Target
₹1,960
At report
₹1,788+10% printed
Vs our close
+29.4%

Motilal Oswal downgrades ICICI Lombard to Neutral (from a prior higher rating) after a significant Q1FY27 miss, with PAT down 46% YoY on a combined ratio of 107.2% driven by two large fire-segment losses and higher motor TP claim reserves following a Supreme Court judgement. The broker cuts FY27/FY28 PAT estimates by 14%/11% and sets a new target price of INR1,960 (28x FY28E EPS), implying 10% upside.

Thesis
  • Gross written premium grew 10% YoY to INR88.6b (in line) and NEP rose 16% YoY to INR59.5b, led by 31% YoY growth in health (incl. PA)
  • Combined ratio surged to 107.2% (vs 101.9% expected, 102.9% in 1QFY26) due to two large fire losses (INR0.63b, 1.0% CoR impact) and INR1.65b increase in Motor TP claim reserves (2.8% CoR impact) after the Supreme Court judgement
  • PAT of INR4b declined 46% YoY, a 45% miss vs estimate, hit by weak underwriting and investment income 12-14% below estimate; excluding one-offs, combined ratio was 102.3% and PAT ~INR5.8b
  • Retail health market share improved to 4.5% from 3.5% YoY, with long-term policy mix rising to 53.4% from 31.8% YoY, indicating structural strength in the health franchise
  • Commercial lines (fire) remain under pricing pressure industry-wide; management prioritizing underwriting discipline over market share, with early signs of pricing stabilization
  • RoE fell to 9.6% in 1QFY27 (13.6% excluding one-offs) vs 20.5% in 1QFY26, reflecting the claims-driven profitability hit
Risks
  • Offset to the higher combined ratio depends on a tariff hike in Motor TP business, commission alterations in Motor, or realignment of Motor OD profitability — visibility on all three is described as bleak
  • Continued irrational pricing competition in the commercial fire insurance segment
  • Evolving judicial landscape on Motor TP claims could require further conservative reserve strengthening
Q1FY27 highlights
  • Gross premium grew 10% YoY to INR88.6b, in line with estimate; NEP grew 16% YoY to INR59.5b
  • Claims ratio at 76.4% (est. 72.4%) vs 73% in Q1FY26; combined ratio at 107.2% vs estimate of 101.9%
  • Underwriting loss of INR6.3b vs loss of INR2.9b in Q1FY26 (vs estimate of INR3.1b)
  • Adjusted/Reported net profit fell 46% YoY to INR4.0b, a 45.4% miss vs estimate of INR7.4b
  • Investment income on policyholders' account INR8.6b (12% below estimate); shareholders' account INR2.9b (14% below estimate)
  • RoE at 9.6% for Q1FY27 vs 20.5% in Q1FY26 (13.6% excluding one-off claims impact)
Broker estimatesUnitFY26FY27EFY28E
NEPINR b222.6251.9283.8
U/W ProfitINR b-11.1-12.5-10.9
PBTINR b36.637.145.7
PATINR b27.72834.5
EPSINR56.356.870
BVPSINR341.9382.3435.8
Claims ratio%71.171.470.4
Combined ratio%103.4103.3102.2
RoE%17.815.717.1
P/Ex31.831.525.6
P/BVx5.24.74.1

Valuation: 28x FY28E EPS. Target price of INR1,960 based on 28x FY28E EPS of INR70.0, implying 10% upside from CMP of INR1,788; rating downgraded to Neutral. NEP estimates maintained, but PAT estimates cut 14%/11% for FY27/FY28 and CoR estimates raised 80bp/20bp following the Q1FY27 claims performance; FY27E PAT is now flat YoY. Rating downgraded from a higher rating to Neutral and target price changed alongside the downgrade.

Extraction note: Report header explicitly flags 'Rating change' and 'Downgrade to Neutral' along with 'TP change' and 'Estimate change', confirming this is a rating downgrade, though the prior rating level is not stated in the extracted text. Last page contains an unrelated promotional insert ('M…

Figures are transcribed from each broker's PDF as printed (units as the broker states them) and are the broker's estimates, not Buoyant's. "Vs our close" recomputes the target against the latest reference close (29 Sept 2026).

SWOT

Strengths · Weaknesses · Opportunities · Threats

Draft
Strengths
  • Buying a franchise leader at a cyclical trough: combined ratio 107.2% in Q1FY27 was inflated by ~490 bps of one-offs (Rs 165 cr SC reserve, Rs 63 cr fire losses); adjusted 102.3% is flat YoY and FY26 was 102.4%, with FY26 ROE still 17.8%.
  • Motor TP repricing is the cyclical lever: tariffs frozen since 2021-22 and IRDAI has proposed an ~18% average hike (Jun-2025); post the 11-Jun-2026 SC homemaker ruling the GI Council is pushing MoRTH for the first hike in four years - ICICI Lombard's motor COR of 106.6% vs industry 128% makes it the biggest relative beneficiary.
  • Health mix shift lifting growth: retail health +51% in FY26 and +50% in Q1FY27 (swung to an operating profit), overall health +69.5% in Q1FY27; health market share up to 4.5% from 3.5%.
  • Balance sheet strength: solvency 2.71x vs 1.5x regulatory, almost debt-free, FY26 investment income Rs 4,742 cr (+11.6%), dividend Rs 13.5/share; supports growth capital for the SC-mandated 4-year/6-year long-term TP covers.
Weaknesses
  • vs Go Digit General Insurance: Go Digit (48x PE, 5.1x P/B, ROE 12.2%, Q1FY27 PAT -38%) is motor-heavy and more exposed to the SC TP ruling at a higher multiple and lower ROE; ICICI Lombard is at 30x with 17.8% FY26 ROE and a diversified health/commercial book.
  • vs Star Health & Allied Insurance: Star Health (39x PE, ROE 7.6%) is a mono-line retail-health insurer with structurally high loss ratios and no motor-TP repricing optionality; ICICI Lombard offers higher ROE at a lower multiple and is gaining retail-health share (+51% FY26 vs Star +11%).
Opportunities
  • MoRTH/IRDAI notification of a motor TP premium revision (IRDAI proposal ~18% average; GI Council request Jul-2026) - decision expected 'in coming quarters'.
  • Q2FY27 results (mid-Oct-2026): confirmation that ex-one-off combined ratio holds at ~102% and that no further SC-related reserve strengthening is needed.
  • Implementation of the 5-Aug-2026 Supreme Court mandate for 4-year (car) / 6-year (2W) long-term TP covers on new vehicles and the uninsured-vehicle (56%) enforcement pilot.
Threats
  • Motor TP tariff hike not materialising: MOFSL notes visibility on TP hike, commission changes and motor-OD realignment is 'bleak'; without it motor TP unit economics stay 'sub-optimal' and loss ratios rise 12-15% from the SC ruling.
  • Growth lag: GDPI grew 7% in FY26 and 8.5% ('n' basis) in Q1FY27 versus industry 9-11% as the company walks away from under-priced motor and commercial lines; commission expense +33% YoY in Q1FY27.
  • Investment income normalising: capital gains fell to Rs 183 cr from Rs 380 cr in Q1FY27; equity-market weakness would compress the ~30% of PBT that comes from realised gains.

Compiled from the approved one-pager (Why We Own What We Own, 8 Sep 2026): why-we-own → strengths, catalysts → opportunities, key risks → threats, peer caveats → weaknesses. Editorial mapping pending review. · author: compiled from the approved one-pager

Research reports · upload with a check step

0 approved · 0 pending · 0 rejected

Only approved reports are readable from the company page; the reviewer must differ from the uploader. Files are hashed (duplicates skipped) and held in the private store.

Internal evidence

Buoyant sources for this name

  • August 2026 top-30 disclosure — rank 8, Insurance, Cyclical. Buoyant AIF I Top 30 Holdings - Aug 2026.pdf
  • One-pager, "Why We Own What We Own" — p36, 8 Sep 2026. Buoyant_Why_We_Own_What_We_Own_Sep2026.pdf (portfolio as of 31 July 2026)
  • Sales playbook, Aug 2026 — holdings matrix (PMS/AIF I/AIF II, $31 Jul 2026). Buoyant_Capital_Sales_Playbook_Aug_2026_Full_Holdings.pdf

Original PDFs are in the supplied package on disk; private object storage is not configured, so source pages are referenced, not served.

Company filings

Investor documents (Tijori knowledge base)

annual reports
  • Annual report FY26
  • Annual report FY25
  • Annual report FY24
  • Annual report FY23
  • Annual report FY22
  • Annual report FY21
earnings releases
  • Results Jan26
  • Results Apr25
  • Results Jul25
  • Results Mar24
  • Results Jun24
  • Results Sep24
  • Results Dec24
  • Results Mar23
  • Results Jun23
  • Results Sep23
  • Results Dec23
  • Results Mar22
investor presentations
  • Presentation Jan26
  • Presentation Apr26
  • Presentation Jul26
  • Presentation Apr25
  • Presentation Jul25
  • Presentation Oct25
  • Presentation Mar24
  • Presentation Jun24
  • Presentation Sep24
  • Presentation Dec24
  • Presentation Mar23
  • Presentation Jun23
conference calls
  • Call Jan26
  • Call Apr26
  • Call Jul26
  • Call Mar25
  • Call Jun25
  • Call Oct25
  • Call Mar24
  • Call Jun24
  • Call Sep24
  • Call Dec24
  • Call Mar23
  • Call Jun23

Links open the issuer's or exchange's document; fetched only through the user's browser, never by the platform.

Ownership

Shareholding · Jun'26

Promoter51.22%
Indian Promoters51.22%
ICICI Bank Limited51.18%
ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITED0.04%
ICICI INVESTMENT MANAGEMENT COMPANY LIMITED0.00%
ICICI HOME FINANCE COMPANY LIMITED0.00%
THE ICICI FOUNDATION FOR INCLUSIVE GROWTH0.00%
RAJASTHAN ASSET MANAGEMENT COMPANY PRIVATE LIMITED0.00%
OTC EXCHANGE OF INDIA0.00%
ICICI TRUSTEESHIP SERVICES LIMITED0.00%
ICICI SECURITIES PRIMARY DEALERSHIP LIMITED0.00%
ICICI PRUDENTIAL TRUST LIMITED0.00%
ICICI BANK UK PLC0.00%
ICICI BANK CANADA0.00%